Cefazolin and Electrocardiogram st segment elevation - a phase IV clinical study of FDA data

Summary:

Electrocardiogram st segment elevation is reported as a side effect among people who take Cefazolin (cefazolin sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Propofol, and have Neuromuscular blockade reversal.

The phase IV clinical study analyzes which people have Electrocardiogram st segment elevation when taking Cefazolin. It is created by eHealthMe based on reports of 15,127 people who have side effects when taking Cefazolin from the FDA, and is updated regularly.

What is Cefazolin?

Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.

What is Electrocardiogram st segment elevation?

Electrocardiogram st segment elevation is found to be associated with 397 drugs and 812 conditions by eHealthMe. Check the latest studies of Electrocardiogram st segment elevation.



On Jul, 09, 2026

15,127 people reported to have side effects when taking Cefazolin.
Among them, 43 people (0.28%) have Electrocardiogram st segment elevation.

Could Cefazolin cause Electrocardiogram st segment elevation?

Among these 43 people:

How long have people been on Cefazolin when they have Electrocardiogram st segment elevation? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Electrocardiogram st segment elevation when taking Cefazolin? *

  • female: 30.95 %
  • male: 69.05 %

What is the age of people who have Electrocardiogram st segment elevation when taking Cefazolin? *

  • 0-1: 0.0 %
  • 2-9: 2.33 %
  • 10-19: 6.98 %
  • 20-29: 4.65 %
  • 30-39: 4.65 %
  • 40-49: 4.65 %
  • 50-59: 34.88 %
  • 60+: 41.86 %

What are other drugs people take besides Cefazolin? *

  1. Propofol: 13 people, 30.23%
  2. Fentanyl: 11 people, 25.58%
  3. Ondansetron: 10 people, 23.26%
  4. Rocuronium Bromide: 9 people, 20.93%
  5. Isoflurane: 8 people, 18.60%
  6. Bridion: 7 people, 16.28%
  7. Suprane: 7 people, 16.28%
  8. Vecuronium Bromide: 6 people, 13.95%
  9. Ultiva: 6 people, 13.95%
  10. Sevoflurane: 6 people, 13.95%

What are other side effects people have besides Electrocardiogram st segment elevation? *

  1. Hypotension (abnormally low blood pressure): 21 people, 48.84%
  2. Hyperhidrosis (abnormally increased sweating): 15 people, 34.88%
  3. Nausea (feeling of having an urge to vomit): 15 people, 34.88%
  4. Arteriospasm Coronary (spasm of the large- or medium-sized coronary arteries): 15 people, 34.88%
  5. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 14 people, 32.56%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 10 people, 23.26%
  7. Chest Pain: 9 people, 20.93%
  8. Kounis Syndrome (the concurrence of heart pain with conditions associated with mast cell activation leads to heart muscle damage): 9 people, 20.93%
  9. Nausea And Vomiting: 9 people, 20.93%
  10. Rashes (redness): 8 people, 18.60%

What are the existing conditions these people have? *

  1. Neuromuscular Blockade Reversal: 8 people, 18.60%
  2. General Anaesthesia: 6 people, 13.95%
  3. Sedation: 5 people, 11.63%
  4. Anaesthesia: 5 people, 11.63%
  5. Brain Contusion (a form of traumatic brain injury): 3 people, 6.98%
  6. Cerebral Haemorrhage (bleeding within the brain): 3 people, 6.98%
  7. Upper Respiratory Tract Infection: 2 people, 4.65%
  8. Gastric Ulcer (stomach ulcer): 2 people, 4.65%
  9. Pain: 2 people, 4.65%
  10. Nerve Block (the interruption of signals travelling along a nerve): 2 people, 4.65%

* Approximation only. Some reports may have incomplete information.

Do you take Cefazolin and have Electrocardiogram st segment elevation?

- Check whether Electrocardiogram st segment elevation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefazolin:

Electrocardiogram st segment elevation treatments and more:

How severe was Electrocardiogram st segment elevation and when was it recovered:

Expand to all the drugs that have ingredients of cefazolin sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefazolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Electrocardiogram st segment elevation:

Browse all the conditions that are associated with Electrocardiogram st segment elevation:


How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium (the active ingredients of Cefazolin) and Cefazolin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: